Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
Published on: August 11, 2023
Decoding salivary gland tumor complexities through omics integration: A systematic analysis across the 21st century
Gustavo de Souza Vieira1, João Figueira Scarini2, Nívia Castro Binda2
1Department of Oral Diagnosis, Piracicaba Dental School, Universidade Estadual de Campinas (UNICAMP), Piracicaba, SP, Brazil; Department of Pathology, Faculty of Medical Sciences, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil; Laboratory of Epithelial Biology, Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI, USA.
Multi-omics integration offers new insights into rare salivary gland tumors (SGTs), advancing molecular classification and identifying therapeutic targets. However, clinical translation of these findings remains limited, requiring further research.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Salivary gland tumors (SGTs) are rare and complex neoplasms.
- Conventional analyses offer limited insights into SGTs' mechanisms and treatment vulnerabilities.
Purpose of the Study:
- To systematically review multi-omics integration studies in human SGTs.
- To assess the impact of multi-omics on understanding SGTs and identify research gaps.
Main Methods:
- Systematic review of studies (2001-2026) using at least two omics layers for SGTs.
- Included 78 studies, predominantly focusing on malignant SGTs like adenoid cystic carcinoma.
- Commonly integrated genomics and transcriptomics, validated with immunohistochemistry and in situ hybridization.
Main Results:
- Multi-omics studies have improved molecular classification and identified prognostic subgroups in SGTs.
- These studies have generated validated in vitro/in vivo models and revealed actionable molecular vulnerabilities.
- Genomic and transcriptomic integration was the most frequent approach.
Conclusions:
- Multi-omics integration has significantly advanced SGT research, revealing key molecular insights.
- Clinical translation of multi-omics findings into precision medicine for SGTs is currently limited.
- Future research should focus on prospective, clinically integrated, and functionally validated multi-omics studies.
More Related Videos
13:01Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024